Cantel Medical logo

CMD - Cantel Medical Share Price

$50.25 1.0  2.0%

Last Trade - 8:45pm

Mid Cap
Market Cap £1.59bn
Enterprise Value £2.25bn
Revenue £782.7m
Position in Universe 1740th / 6366
Unlock CMD Revenue
Relative Strength (%)
1m +7.53%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -47.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jul 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
488.7 565 664.8 770.2 871.9 918.2 995.9 1,117 +13.4%
+13.6 +15.0 +25.1 +20.0 +17.3 -5.1 -40.0 +59.1
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 April 2020, Cantel Medical Corp. revenues increased 15% to $782.7M. Net income applicable to common stockholders excluding extraordinary items decreased 70% to $14M. Revenues reflect Dental segment increase from $116.2M to $247.5M, United States segment increase of 15% to $574.4M, Europe/Africa/Middle East segment increase of 20% to $128M, Asia/Pacific segment increase of 16% to $54.1M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CMD Revenue Unlock CMD Revenue

Net Income

CMD Net Income Unlock CMD Revenue

Normalised EPS

CMD Normalised EPS Unlock CMD Revenue

PE Ratio Range

CMD PE Ratio Range Unlock CMD Revenue

Dividend Yield Range

CMD Dividend Yield Range Unlock CMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CMD EPS Forecasts Unlock CMD Revenue
Profile Summary

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.

Last Annual July 31st, 2019
Last Interim April 30th, 2020
Incorporated August 16, 1963
Public Since April 19, 1995
No. of Shareholders: 303
No. of Employees: 2,775
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P 400 Mid Cap , S&P Composite 1500 ,
Exchange New York Stock Exchange
Shares in Issue 42,154,298
Free Float (0.0%)
Eligible for
CMD Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CMD
Upcoming Events for CMD
Monday 21st September, 2020 Estimate
Q4 2020 Cantel Medical Corp Earnings Release
Tuesday 8th December, 2020 Estimate
Q1 2021 Cantel Medical Corp Earnings Release
Thursday 17th December, 2020 Estimate
Cantel Medical Corp Annual Shareholders Meeting
Frequently Asked Questions for Cantel Medical
What is the Cantel Medical share price?

As of 8:45pm, shares in Cantel Medical are trading at $50.25, giving the company a market capitalisation of £1.59bn. This share price information is delayed by 15 minutes.

How has the Cantel Medical share price performed this year?

Shares in Cantel Medical are currently trading at $50.25 and the price has moved by -46.04% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cantel Medical price has moved by -52.46% over the past year.

What are the analyst and broker recommendations for Cantel Medical?

Of the analysts with advisory recommendations for Cantel Medical, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cantel Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Cantel Medical next release its financial results?

Cantel Medical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-04-30
What is the Cantel Medical dividend yield?

The Cantel Medical dividend yield is 0.2% based on the trailing twelve month period.

Does Cantel Medical pay a dividend?

Last year, Cantel Medical paid a total dividend of 0.1, and it currently has a trailing dividend yield of 0.2%. Looking ahead, Cantel Medical has not announced an ex-dividend date yet.

When does Cantel Medical next pay dividends?

Cantel Medical has yet to annouce their ex-dividend date. The historic dividend yield on Cantel Medical shares is currently 0.2%.

How do I buy Cantel Medical shares?

To buy shares in Cantel Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cantel Medical?

Shares in Cantel Medical are currently trading at $50.25, giving the company a market capitalisation of £1.59bn.

Where are Cantel Medical shares listed? Where are Cantel Medical shares listed?

Here are the trading details for Cantel Medical:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: CMD
What kind of share is Cantel Medical?

Based on an overall assessment of its quality, value and momentum, Cantel Medical is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cantel Medical share price forecast 2020?

Shares in Cantel Medical are currently priced at $50.25. At that level they are trading at 31.95% discount to the analyst consensus target price of 0.00.

Analysts covering Cantel Medical currently have a consensus Earnings Per Share (EPS) forecast of 1.234 for the next financial year.

How can I tell whether the Cantel Medical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cantel Medical. Over the past six months, the relative strength of its shares against the market has been -18.91%. At the current price of $50.25, shares in Cantel Medical are trading at -8.39% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cantel Medical PE Ratio?

The Cantel Medical PE ratio based on its reported earnings over the past 12 months is 33.24. The shares are currently trading at $50.25.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Cantel Medical?

Cantel Medical's management team is headed by:

Charles Diker - CHM
Alan Batkin - LED
Eric Nodiff - EVP
Mark Diker - DRC
George Fotiades - PRE
Ann Berman - IND
Seth Yellin - EVP
Peter Clifford - COO
Laura Forese - IND
Anthony Evnin - IND
Brian Capone - SVP
Dottie Donnelly-Brienza - CHO
Lawrence Conway - SVP
Bill Haydon - SVP
Jean Casner - CHO
Shaun Blakeman - CFO
Jeffrey Mann - SVP
Karen Prange - DRC
Who are the major shareholders of Cantel Medical?

Here are the top five shareholders of Cantel Medical based on the size of their shareholding:

Brown Capital Management, LLC Investment Advisor
Percentage owned: 9.29% (3.92m shares)
Diker (Charles M) Individual Investor
Percentage owned: 9.16% (3.86m shares)
Champlain Investment Partners, LLC Investment Advisor
Percentage owned: 8.71% (3.67m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.14% (3.43m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 7.65% (3.22m shares)
Similar to CMD
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.